HUMAN UMBILICAL WHARTON'S JELLY MESENCHYMAL STEM CELL VESICLES
Safety score · 0–100
Moderate
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
About
Total vesicle fraction from human Wharton's jelly MSC culture, including exosomes and other membrane-bound signalling particles.
Human umbilical Wharton's jelly MSC vesicles encompass the broader vesicle fraction from MSC culture, regulated under EU Annex II/416 for materials of human origin. Unlike purified exosomes, this fraction includes all vesicle types (exosomes, microvesicles, apoptotic bodies), making the composition broader and less defined than exosome isolates. The vesicles contain the lipid membrane-bound cargo of the cells and may include a wider range of bioactive molecules. Full safety documentation is required for EU market access.
Skin benefits
- Broad vesicle cargo from Wharton's jelly MSCs
- Contains multiple vesicle types with diverse bioactive cargo
- Documented regenerative properties in MSC vesicle literature
Known concerns
- EU Annex II/416 restriction
- Vesicle fraction is less defined than purified exosomes
- Includes heterogeneous vesicle population
- Donor screening and pathogen testing required
References
EU CosIng database
European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.
Check your shelf
Find HUMAN UMBILICAL WHARTON'S JELLY MESENCHYMAL STEM CELL VESICLES in your products.
Scan any cosmetic product with LuxSense to see if it contains HUMAN UMBILICAL WHARTON'S JELLY MESENCHYMAL STEM CELL VESICLES and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.